Metabolic Bariatric Surgery Across the IFSO Chapters: Key Insights on the Baseline Patient Demographics, Procedure Types, and Mortality from the Eighth IFSO Global Registry Report - Scorecard - MDSpire
Advertisement
Metabolic Bariatric Surgery Across the IFSO Chapters: Key Insights on the Baseline Patient Demographics, Procedure Types, and Mortality from the Eighth IFSO Global Registry Report
Clinical Scorecard: Insights on Patient Demographics, Surgical Procedures, and Mortality in Metabolic Bariatric Surgery: Findings from the Eighth Global Registry Report by IFSO
At a Glance
Category
Detail
Condition
Obesity and obesity-related diseases including diabetes, hypertension, and cardiovascular disease
Key Mechanisms
Metabolic bariatric surgery (MBS) induces weight loss and remission of obesity-related diseases
Target Population
People with obesity undergoing metabolic bariatric surgery worldwide
Care Setting
Surgical centers and national/regional bariatric surgery registries
Key Highlights
MBS is effective and safe for weight loss and remission of obesity-related diseases as demonstrated by RCTs and cohort studies.
The IFSO Global Registry collects aggregated data from established national and regional registries to provide real-world surveillance of MBS procedures and demographics.
Data from 24 countries and 2 regional registries covering 502,150 MBS procedures showed 89.6% were primary and 10.4% revisional procedures, with varying case ascertainment rates.
Guideline-Based Recommendations
Diagnosis
Use registry data to identify patient demographics and procedure types for metabolic bariatric surgery.
Management
Perform primary MBS as first-line surgical intervention for obesity; consider revisional procedures for conversions or complications.
Utilize national or regional registries to monitor surgical practice and outcomes.
Monitoring & Follow-up
Collect and analyze aggregated data on MBS procedures to track safety indicators and procedural trends.
Ensure data completeness and accuracy through established registries with high case ascertainment.
Risks
Recognize potential data limitations due to aggregated reporting and incomplete data alignment across registries.
Be aware of privacy regulations (e.g., GDPR) influencing data collection and sharing.
Patient & Prescribing Data
Individuals undergoing metabolic bariatric surgery across multiple countries and regions.
Majority undergo primary MBS procedures; revisional surgeries account for about 10%, with higher rates in some countries like Australia.
Clinical Best Practices
Contribute to and utilize national or regional bariatric surgery registries for comprehensive data collection.
Adopt standardized data dictionaries to improve data consistency across registries.
Use aggregated data reporting to comply with privacy regulations while enabling global surveillance.
Engage multidisciplinary teams to interpret registry data and improve patient outcomes.
by Wendy A. Brown, Ronald Liem, Salman Al-Sabah, Mehran Anvari, Camilo Boza, Ricardo V. Cohen, Amir Ghaferi, Villy Våge, Jacques Himpens, Lilian Kow, John Morton, Mario Musella, Francois Pattou, Nasser Sakran, Benjamin Clapp, Gerhard Prager, Scott Shikora
A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation
